FDA Clearance Tracker · P150038-S036
Exablate Neuro, Exablate Prime, Exablate Transcranial MRgFUS, Exablate Model 4000, Exablate Neuravive
Last checked: Nov 20, 2026Latest source record: Oct 8, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Oct 8, 2024
Approved
Time to decision
174 days
Received Apr 17, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150038-S036
- Device name
- Exablate Neuro, Exablate Prime, Exablate Transcranial MRgFUS, Exablate Model 4000, Exablate Neuravive
- Applicant
- Insightec
- Applicant location
- Tirat Carmel
- Received
- Apr 17, 2024
- Decided
- Oct 8, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P150038
Device type
- Device type
- MR-guided focused ultrasound system (POH)
- Device class
- Class III
- Specialty
- Neurology & Neurosurgery
FDA's approval statement
As written in FDA's record.
approval for the Exablate Model 4000 Type 1.1 System software version 9.0.1 to be compatible with Philips 1.5 Tesla (T) and 3.0 T magnetic resonance imaging (MRI) scanners, and the hardware and labeling were modified accordingly as a result of this proposed change. In addition, the P150038/S036 application proposed the following changes to the subject device: Expanded tractography support, to allow the display of overlapping anatomical structures. Added baseline thermometry averaging (compared to approved baseline calculation using the last cold phase image), for enhanced sound-to-noise ratio (SNR), within approved specifications. Added a visual indication of auto-calibration process bar and tracking planning scan acquisition. Enhanced cavitation monitoring mechanism requirements, to further improve the robustness of the monitoring to sporadic noises and reduce false cavitation alerts. Added additional thermometry protocols for GE and Siemens MRI scanners as additional options for users.
Source documents
Other decisions for Insightec
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Exablate Model 4000 Type-1 SystemPMA supplement
P150038-S037 · Decided Jul 3, 2025 · 352 days after receipt · Panel Track
Device type: MR-guided focused ultrasound system (POH) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.